← Back to all signals
RESEARCH PAPER ANALYSIS

Targeting relapsed/refractory and MRD + Ph + ALL: olverembatinib-venetoclax bridging enhances allo-HSCT outcome​.

AI interpretation is pending for this paper.

Open original publication →
PMID41388081
JournalAnnals of hematology
Publication Date2025-12-13
Ingested2026-08-02 12:05 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

Olverembatinib is a novel third-generation TKI available in mainland China. However, there are only a few published clinical reports. In this study, we aimed to investigate the efficacy and safety of an olverembatinib-venetoclax regimen before bridging to HSCT in adult Ph/BCR-ABL1 + ALL patients with refractory/relapsed disease (n = 2) or persistent minimal residual disease (MRD) (n = 15). Seventeen Ph + ALL patients who were admitted to our center between February 2022 and January 2023 were enrolled. Four patients harbored a T315I mutation. In all, 100% achieved hematologic complete remission, and 70.6% achieved complete molecular remission. With a median follow-up of 856-day post-HSCT, the 2-year overall survival and relapsed free survival rates was 88.2 ± 7.8% and 79.4 ± 10.9%, respectively. The findings of this study suggest that in Ph + ALL patients with disease recurrence and persistent MRD positivity, olverembatinib-venetoclax regimen showed a high molecular response rate and was well-tolerated in MRD clearance bridged to allo-HSCT.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Couple-Level Coping and Hope Interdependence in Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolisation: Insights From an Actor-Partner Interdependence Model. Journal of nursing management 63.0 2 Applying the Best Interests Standard in Pediatric Palliative Care: A Case Study. Narrative inquiry in bioethics 57.2 3 Multicenter analysis of [123I/131I]I-mIBG imaging in pediatric neuroblastoma - effective dose estimation. Nuclear medicine review. Central & Eastern Europe 68.12 4 Spontaneous regression of dentigerous cyst in a impacted mandibular first permanent molar with eruptive potential: a case report. BMC oral health 52.4 5 [Correlation Between Molecular Genetic Features and Clinical Prognosis in Pediatric Burkitt Lymphoma]. Zhongguo shi yan xue ye xue za zhi 72.3 6 [Clinical Observation of Donor-Derived NK Cell Infusion in the Prevention of Cytomegalovirus Infection after Haploidentical Hematopoietic Stem Cell Transplantation]. Zhongguo shi yan xue ye xue za zhi 69.7 7 An Implementation Model for Oncofertility Support in a Regional Cancer Center without an In-House Reproductive Medicine Unit. The Kobe journal of medical sciences 60.4 8 Clinical significance of serum ATP8B1 in children with Mycoplasma pneumoniae infection complicated with myocardial injury. Annals of agricultural and environmental medicine : AAEM 52.4 9 Clinical significance of serum miR-95 in children with Mycoplasma pneumoniae infection complicated with diarrhea. Annals of agricultural and environmental medicine : AAEM 53.0 10 The miR-877-3p polymorphism rs1264440 is associated with susceptibility to breast cancer. Annals of agricultural and environmental medicine : AAEM 48.5 11 Whole-Body MRI in Neurocutaneous Syndromes: Imaging Phenotypes, Surveillance Strategies, and Pitfalls. Journal of computer assisted tomography 60.6 12 Metastatic Neuroblastoma Arising in an Ovarian Immature Teratoma in a 16-Year-Old Female: A Case Report. Fetal and pediatric pathology 54.7 13 Cardiovascular Disease Risk Among Childhood and Young Adult Cancer Survivors: A Systematic Review and Meta-Analysis. JAMA pediatrics 74.2 14 Comment on: Assessment of Immunization Status Following Non-HSCT Chemotherapy-Treated Pediatric Leukemia Survivors-Toward Recovery-Guided Revaccination. Journal of pediatric hematology/oncology 53.44 15 Effects of Palliative Oral Etoposide on Survival and Treatment Burden in Patients With Relapsed/Refractory Pediatric Malignancies. Journal of pediatric hematology/oncology 66.5 16 Aboriginal and Torres Strait Islander adolescent and parent perspectives on human papillomavirus vaccination through the School Immunisation Program in Queensland, Australia: a qualitative study. Vaccine 61.5 17 Teratoid Wilms Tumor: A Patient-Level Systematic Review of the Published Literature. Journal of pediatric surgery 74.6 18 The Evolving Landscape of Extracorporeal Photopheresis in Immunotherapy: A Comprehensive Bibliometric and Topic Modeling Analysis (1995-2024). Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 73.22 19 Developmental experiences of female patients diagnosed with Peutz-Jeghers syndrome in childhood: a qualitative study based on the social ecological model in China. BMJ open 60.4 20 Quantifying the health and financial burden of adverse childhood experiences in Wales, England and English regions in 2023: a pooled analysis of 10 population surveys. BMJ open 74.6 21 Adherence and weight loss with a total diet replacement programme for increased cancer risk associated with obesity: a UK cohort study. BMJ open 69.0 22 Comparative clinical outcomes and single-cell profiling of CD19 CAR-T versus blinatumomab for relapsed/refractory B-ALL. Journal for immunotherapy of cancer 80.84 23 Beyond Research Priorities: Stakeholder-Identified Health System Challenges From an Australian Childhood Cancer Priority-Setting Partnership. Health expectations : an international journal of public participation in health care and health policy 62.9 24 Solid Malignant Tumors in Infancy: A Single-Center Experience. Journal of pediatric hematology/oncology 65.6 25 The Role of STAG2, CDKN2A, and TP53 Genes in Ewing Sarcoma: A Report of a Rare Case of Primary Ewing Sarcoma of the Kidney With Favorable Outcome. Journal of pediatric hematology/oncology 47.1 26 Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer (CHN HYPOPMRT): 10-year outcomes from a randomised, non-inferiority, open-label, phase 3 trial. The Lancet. Oncology 87.54 27 Knowledge and attitudes of medical students about human papillomavirus (HPV) and HPV vaccine: A cross-sectional survey in Inner Mongolia, China. Human vaccines & immunotherapeutics 62.9 28 HMGA2-Rearranged Lipoblastoma in an Adult Patient With Novel GRIP1 Gene Fusion Partner. Cureus 54.0 29 AGK::BRAF fusion activates MAPK signaling, promotes genomic instability, and reduces NIS expression in thyroid cancer cells. Endocrine oncology (Bristol, England) 56.0 30 Comparison of Remimazolam and Propofol for Anesthesia Management in Liver Cancer Patients Undergoing Percutaneous Radiofrequency Ablation: A Randomized Controlled Trial. Drug design, development and therapy 80.6 31 Radiological signatures and health risks of natural radionuclides in the Nubian Sandstone Aquifer across Egypt's Western Desert oases. Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 58.7 32 [Analysis of risk factors for pathological upgrading after cervical conization in patients with CIN1]. Zhonghua fu chan ke za zhi 65.4
PATIENT-FRIENDLY SUMMARY

Targeting relapsed/refractory and MRD + Ph + ALL: olverembatinib-venetoclax bridging enhances allo-HSCT outcome​.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic